

Indian pennywort, hydrocotyle, mandukaparni, madecassol, TECA, centelase, tsubo-kusa, luei gong gen, idrocotyle, kaki kuda
Extracts from the leaf and the entire plant of gotu kola are used for a variety of conditions including venous insufficiency, varicose veins, wound healing, scleroderma, and scars.
In vitro and in vivo analyses indicate that gotu kola has neuroprotective (13) and chemopreventive (14) (19) properties, and protects against cognitive impairment (20). Madecassoside, an active constituent, also exerts protective effects against arthritis (5) and myocardial infarction (4).
Topical application of an asiaticoside extracted from gotu kola enhanced burn wound healing (6), and an herbal preparation containing gotu kola was effective against chronic periodontitis (15). Supplementation with gotu kola improved cognitive function and mood in the elderly (7), and alleviated generalized anxiety disorder (16). Data also show a reduction in lower extremity edema with gotu kola compared to placebo in patients with chronic venous insufficiency (1) (2) (3).
Gotu kola should not be confused with kolanut. Gotu kola does not contain any caffeine and has not been shown to have stimulant properties.
The triterpenoids are considered to be the active constituents in gotu kola. The glycoside madecassoside has anti-inflammatory properties. Asiaticoside, a constituent of gotu kola, appears to promote wound healing by stimulating collagen and glycosaminoglycan synthesis as well as angiogenesis (6). It also elevates blood glucose and cholesterol levels. There is preliminary evidence that gotu kola might have sedative and analgesic properties (9).
Wattanathorn J, et al. Positive modulation of cognition and mood in the healthy elderly volunteer following the administration of Centella asiatica. J Ethnopharmacol. Mar 5 2008;116(2):325-332.
In this randomized, placebo-controlled, double-blind study, 28 participants (> 61 years of age) were given gotu kola extracts (250, 500, or 750 mg daily) or placebo to determine the effect of gotu kola on cognitive function and mood. After 2 months, cognitive function (as assessed by event-related potential and the computerized assessment battery test) and mood (using Bond-Lader visual analogue) were determined. The greatest improvements in mood and cognitive function were detected in subjects who received 750 mg dose of gotu kola.
Larger, long-term studies are warranted.
Bottom Line: Gotu kola has not been shown to treat or prevent cancer.
Gotu kola is a plant extract that contains many biologically active compounds. Although this botanical has been studied extensively in the laboratory, very few studies have been conducted in humans. Laboratory studies have found a range of effects including improved wound healing and anti-inflammatory effects. Studies in humans have suggested that gotu kola can decrease venous pressure in people with venous insufficiency and may be able to relieve anxiety.
In this randomized, placebo-controlled, double-blind study, 28 participants (> 61 years of age) received either gotu kola extracts (250, 500, or 750 mg daily) or placebo to determine the effect of gotu kola on cognitive function and mood. After 2 months, cognitive function and mood were determined. The greatest improvements in mood and cognitive function were seen in those who received the 750 mg dose of gotu kola. More research is needed.